EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 32 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9 | -99.6% | 1 | -99.5% | 0.00% | – |
Q3 2022 | $2,000 | – | 195 | +441.7% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 36 | -100.0% | 0.00% | -100.0% |
Q3 2021 | $1,634,000 | -63.7% | 98,395 | -53.4% | 0.00% | -50.0% |
Q2 2021 | $4,505,000 | +64.9% | 211,168 | +151.2% | 0.00% | +100.0% |
Q1 2021 | $2,732,000 | – | 84,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $50,494,000 | 11.75% |
Novo Holdings A/S | 5,587,207 | $181,584,000 | 7.50% |
Orbimed Advisors | 13,944,680 | $453,202,000 | 4.24% |
Logos Global Management LP | 1,056,812 | $34,346,000 | 3.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $127,827,000 | 2.69% |
EcoR1 Capital, LLC | 1,224,175 | $39,786,000 | 1.76% |
Cormorant Asset Management, LP | 2,340,914 | $74,307,000 | 1.66% |
Octagon Capital Advisors LP | 125,000 | $4,063,000 | 1.53% |
RA Capital Management | 2,613,623 | $84,943,000 | 1.28% |
Soleus Capital Management, L.P. | 100,000 | $3,250,000 | 0.59% |